Optical nanoprobes in biomedical diagnosis assays: Recent progress

Abstract

Biomedical assays based on optical nanoprobes play an important role in human health. Optical nanoprobes, the nanomaterials with special optical properties, are widely utilized in biomedical assays. Compared with traditional materials, the well-performed optical nanoprobes have certain properties, such as negligible interferences from the background fluorescence and scattering, simple operations and instruments, high sensitivity, and excellent specificity. This paper reviews the mechanisms, materials, and applications of optical nanoprobes. The mechanisms of optical nanoprobes involve fluorescence, phosphorescence, Förster resonance energy transfer (FRET), upconversion luminescence and chemiluminescence. Time-resolved luminescent nanoprobes are usually prepared from rare earth compounds and quantum dots (QDs). Ultralong inorganic phosphorescent nanoprobes are prepared from transition metal compounds, while ultralong organic phosphorescent nanoprobes are usually prepared from π-conjugated compound nanocrystals that exhibit a rigid confinement to suppress the non-radiative transitions and contain heavy atoms to enhance ISC. Time-resolved luminescent nanoprobes and ultralong phosphorescent nanoprobes minimize background interferences by longer luminescence lifetime. Chemiluminescent nanoprobes are usually prepared from compounds that can react with reactive oxygen species (ROS) to form peroxide bonds. Upconversion luminescent nanoprobes are usually prepared from inorganic rare earth fluoride nanocrystals. Chemiluminescent nanoprobes and upconversion luminescent nanoprobes can avoid background interferences because excitation light of shorter wavelength is not needed. FRET nanoprobes and luminescence quenching nanoprobes are prepared from a donor and an acceptor that can be linked or delinked by the analyte. Optical nanoprobes are applied in both in vitro diagnoses and in vivo imaging. The in vitro applications of optical nanoprobes include the determination of varieties of biomacromolecules and small molecules, while the in vivo imaging involves the diagnoses of inflammation and tumors.